Excellent Brain to Bring ADHD Neurofeedback Training into Schools

Excellent Brain, a developer of neurofeedback training technology, has signed a partnership with Scholas Occurrentes, the international educational foundation, to deliver ADHD-focused neurofeedback programs in schools and universities worldwide.

The agreement makes neurofeedback training — a non-pharmacological intervention in which users learn to modulate their own brain activity, typically through real-time EEG feedback — available to student populations at scale. Excellent Brain supplies the training platform; Scholas Occurrentes provides the global network of educational institutions through which the programs will run.

ADHD affects a substantial share of school-age children, and current first-line treatment relies heavily on stimulant medication. Neurofeedback has been studied for decades as a complementary approach: patients complete repeated training sessions while an EEG system records their cortical activity and translates it into visual or auditory feedback, rewarding patterns associated with improved attention. Excellent Brain's product line is built around this model of attention training delivered through consumer-accessible hardware and guided protocols.

For the collaboration, the two organizations plan to deploy the training within existing school and university infrastructures rather than through standalone clinics. Scholas Occurrentes, founded with roots in Latin America and now operating across multiple continents, works with educational communities in dozens of countries — a footprint that gives the partnership a wide potential distribution channel for the training programs.

The clinical context matters. Neurofeedback for ADHD remains an actively investigated field. Meta-analyses of EEG neurofeedback trials in pediatric ADHD have reported attention benefits in some settings, while others have questioned whether gains exceed placebo expectation effects, particularly when raters are unblinded. Excellent Brain's programs as deployed in schools should be read as training and support tools delivered in educational settings, not as diagnostic or clinical treatment devices — scalp EEG recorded in a classroom is not a substitute for a formal diagnostic EEG evaluation in a qualified lab.

For neurophysiology readers, the deployment raises familiar practical questions. School-based neurofeedback depends on the quality of the EEG signal acquisition, the robustness of artifact rejection in uncontrolled environments, protocol adherence across many sessions, and appropriate supervision. Educational staff administering attention-training programs typically operate far from the standards of a monitoring unit, so the burden falls on the platform's design — automated feedback, standardized protocols — to keep the training consistent.

The partnership also signals a broader trend: the movement of EEG-based interventions out of clinics and research labs and into everyday institutional settings. Companies in the consumer neurotechnology space increasingly position attention training for students, athletes and professionals as a wellness and performance product. The Excellent Brain–Scholas Occurrentes arrangement follows that pattern, pairing a technology vendor with an organization that has direct, sustained access to the target population.

Neither party has disclosed in the announcement the number of institutions that will participate initially, the training protocol details, or a timeline for rollout across specific countries. The companies say the programs will reach schools and universities worldwide through the foundation's network.

For clinicians following ADHD interventions, the initiative is worth watching as a large-scale test of whether school-delivered EEG neurofeedback can be implemented consistently outside controlled research settings — and whether real-world educational outcomes in participating student cohorts will be measured and reported.